WAY-305025 is primarily used in scientific research as a selective antagonist for the 5-HT6 receptor, making it a valuable tool in neuroscience and pharmacology studies. It has been investigated for its potential to modulate cognitive functions, particularly in models related to Alzheimer's disease and other cognitive disorders. By blocking the 5-HT6 receptor, WAY-305025 helps researchers understand the role of serotonin signaling in learning, memory, and behavior. It has shown procognitive effects in preclinical models, enhancing performance in memory and attention tasks. Due to its specificity, it is often used to validate the therapeutic potential of 5-HT6 receptor modulation without the confounding effects seen with less selective compounds. Its application remains confined to laboratory and experimental settings, supporting drug discovery efforts for central nervous system disorders.